HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A 12-month prospective study of gasserian ganglion stimulation for trigeminal neuropathic pain.

AbstractAIMS:
Trigeminal neuropathic pain is a broad diagnostic category that includes pain of several etiologies and excludes trigeminal neuralgia. The authors report a prospective series of percutaneous gasserian ganglion stimulation for trigeminal neuropathic pain.
METHODS:
Patients who experienced >50% reduction in pain from a 7- to 10-day trial period underwent permanent implantation and were prospectively followed.
RESULTS:
Eight of 10 trialed patients received a permanent implant. At the 12-month follow-up, 2 patients had been explanted and 1 was lost to follow-up. Three (all working at that the time) continued to experience >50% improvement in pain.
DISCUSSION:
The results in this series were variable but 3 patients showed long-term improvements. Patients who continued to work responded better to treatment.
AuthorsA Machado, M Ogrin, J M Rosenow, J M Henderson
JournalStereotactic and functional neurosurgery (Stereotact Funct Neurosurg) Vol. 85 Issue 5 Pg. 216-24 ( 2007) ISSN: 1011-6125 [Print] Switzerland
PMID17534134 (Publication Type: Journal Article)
CopyrightCopyright (c) 2007 S. Karger AG, Basel.
Topics
  • Adult
  • Aged
  • Disability Evaluation
  • Electric Stimulation Therapy (methods)
  • Electrodes, Implanted
  • Employment
  • Female
  • Fluoroscopy
  • Heart Septum (radiography)
  • Humans
  • Male
  • Middle Aged
  • Pain Measurement
  • Prospective Studies
  • Quality of Life
  • Stereotaxic Techniques
  • Time Factors
  • Treatment Outcome
  • Trigeminal Ganglion (physiopathology)
  • Trigeminal Neuralgia (physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: